1.415

1.05% -0.015

Telomir Pharmaceuticals Inc (TELO)

Overview News Price History Discussions Forecast

Telomir Pharmaceuticals Inc stock is traded at $1.415, with a volume of 119.22K. It is down -1.05% in the last 24 hours and down -9.87% over the past month. Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Previous Close:

$1.43

Open:

$1.42

24h Volume:

119.22K

Relative Volume:

0.04

Market Cap:

$49.16M

Revenue:

Net Income/Loss:

$-16.14M

P/E Ratio:

-2.6204

EPS:

-0.54

Net Cash Flow:

$-3.99M

1W Performance:

+4.81%

1M Performance:

-9.87%

6M Performance:

-44.29%

1Y Performance:

-68.13%

1-Day Range:

$1.39

$1.42

1-Week Range:

$1.2747

$1.44

52-Week Range:

$1.12

$7.0791

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name

Telomir Pharmaceuticals Inc

Sector

Healthcare (1143)

Industry

Biotechnology (634)

Phone

786-396-6723

Address

100 SE 2ND ST, MIAMI

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

TELO's Discussions on Twitter

Compare TELO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TELO Telomir Pharmaceuticals Inc	1.4151	49.16M	0	-16.14M	-3.99M	-0.54
ARGX Argen X Se Adr	922.57	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	201.56	43.00B	447.02M	-1.18B	-906.14M	-6.1812
VRTX Vertex Pharmaceuticals Inc	422.63	110.50B	11.74B	3.68B	3.34B	14.19
ONC Beone Medicines Ltd Adr	356.57	40.27B	4.98B	69.59M	525.67M	0.5197
REGN Regeneron Pharmaceuticals Inc	705.51	76.23B	14.25B	4.58B	3.88B	41.77

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	Rodman & Renshaw	Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

07:53 AM

Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN

07:53 AM

07:26 AM

Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com

07:26 AM

05:27 AM

Does Telomir Pharmaceuticals Inc. stock trade at a discount to peers2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com

05:27 AM

04:59 AM

Will Telomir Pharmaceuticals Inc. bounce back from current supportEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com

04:59 AM

12:26 PM

Has Telomir Pharmaceuticals Inc. found a price floor2025 Technical Overview & Safe Swing Trade Setups - newser.com

12:26 PM

Nov 18, 2025

How Telomir Pharmaceuticals Inc. stock performs after earnings - newser.com

Nov 18, 2025

Nov 17, 2025

What technical models suggest about Telomir Pharmaceuticals Inc.’s comebackFed Meeting & Daily Oversold Bounce Ideas - newser.com

Nov 17, 2025

Nov 16, 2025

What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Sell Signal & High Win Rate Trade Tips - newser.com

Nov 16, 2025

Will Telomir Pharmaceuticals Inc. rebound enough to break even2025 Retail Activity & Reliable Trade Execution Plans - newser.com

Nov 16, 2025

Nov 15, 2025

What Institutional Trends Suggest About Harshdeep Hortico Limiteds DirectionStock Watchlist Updates & Explosive Capital Growth - earlytimes.in

Nov 15, 2025

Is Telomir Pharmaceuticals Inc a good long term investmentCandlestick Pattern Analysis & Budget Friendly Portfolio - earlytimes.in

Nov 15, 2025